Fulvestrant plus capivasertib for metastatic breast cancer - Authors' reply
Citation
Jones RH, Casbard A, Carucci M, Foxley A, Howell SJ. Fulvestrant plus capivasertib for metastatic breast cancer - Authors' reply. Lancet Oncol. 2020;21(5):e234.Journal
Lancet OncologyDOI
10.1016/s1470-2045(20)30237-0PubMed ID
32359499Additional Links
https://dx.doi.org/ 10.1016/s1470-2045(20)30237-0Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/s1470-2045(20)30237-0